4
Changes in Ownership
MoonLake Immunotherapeutics Filed Acc 0001213900-20-032863
CEO and Chairman bought 430,000 shares at $10.00 ($4,300,000)
From the SEC's structured data for this filing
MoonLake Immunotherapeutics Filed Acc 0001213900-20-032863
CEO and Chairman bought 430,000 shares at $10.00 ($4,300,000)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…